【EXPERT Q&A】Overseas buyers already have fixed suppliers. Why are they still looking for new Chinese manufacturers?

November 16, 2026  Source: drugdu 41

Drugdu.com expert's respons

 

When engaging in foreign trade of pharmaceuticals and medical devices, some overseas buyers will mention in their inquiries that they already have suppliers they have worked with for many years, and they only hope to learn about other manufacturers.

For suppliers, this type of inquiry can sometimes be confusing. Since the buyer already has a stable procurement channel, why are they still looking for new manufacturers? Are they just trying to get a quote to pressure their existing supplier into lowering prices? If there are no short-term procurement plans, is it still necessary to invest time in follow-up?

This scenario is quite common in pharmaceutical procurement. Many overseas pharmaceutical factories, medical device distributors and large importers will regularly look for new supply sources even when their current suppliers are performing well. Enterprises aim to maintain the stability of their procurement channels while avoiding over-reliance on a single manufacturer.

Why can long-term cooperating suppliers still fail to meet all procurement needs?

For pharmaceutical companies, the continuity of raw material supply is extremely critical. If a certain API is long-term dependent on a single manufacturer, downstream formulation production may be affected once the production line encounters maintenance, insufficient capacity, quality issues or delivery delays.

As a result, some pharmaceutical factories will proactively assess other qualified manufacturers in advance and add them to their alternative supplier lists. Even if current orders are still fulfilled by the original supplier, they want to have alternative supply sources available in a timely manner when the need arises in the future.

Similar situations exist in medical consumables procurement. For example, an overseas distributor has long sold a certain brand of medical dressings or disposable catheters, but when the original supplier suddenly adjusts the MOQ, extends the lead time, or cannot provide certain specifications, the distributor may start looking for new manufacturers.

Some buyers seek second suppliers to diversify supply risks, some to expand product specifications or broaden sales channels, and others hope to understand the current market price level through market inquiries.

Therefore, when overseas buyers take the initiative to look for new suppliers, it does not necessarily mean that the original cooperation has encountered problems, nor does it mean that the buyer is immediately preparing to replace the manufacturer.

How far is it from being an alternative supplier to receiving an official order?

For products such as APIs and pharmaceutical excipients, whether a new supplier can be included in the procurement system usually requires quality assessment.

For example, after an overseas pharmaceutical factory finds a new API manufacturer, they will first confirm the product quality standards, production entities, GMP compliance and relevant registration documents. Subsequently, the quality department may also request samples, batch testing data, stability information, and even conduct supplier audits.

Some raw materials also involve formulation production process adaptation, validation or registration changes. Even if the new supplier's product indicators meet the requirements, the pharmaceutical factory may not immediately switch the procurement source.

ICH Q7 has put forward relevant requirements for the assessment of critical material suppliers and the change control of supply sources. This also reflects that in the pharmaceutical industry, selecting a new supply source often requires completing the necessary quality and change assessments.

For medical device distributors, adding a new supplier may involve issues such as product certification, model adaptation, local registration, packaging and labeling, after-sales support, and end-customer acceptance.

Therefore, when a buyer states that they are looking for an Alternative Supplier or Second Source, this can be regarded as a clear supplier development demand, but the actual procurement opportunity needs to be judged in combination with the project progress.

What can new suppliers rely on to attract buyers' attention?

Some enterprises, upon learning that the buyer already has a fixed supplier, will try to win cooperation by offering a lower quotation.

Price certainly affects procurement decisions, but for pharmaceutical products that require long-term and stable supply, buyers usually also compare product quality, production capacity, document support and delivery reliability.

For example, an API enterprise that can provide quality standards that meet the buyer's requirements, clear production sources, stable batch quality data and necessary registration support may qualify for the next round of assessment even if its quotation is not significantly lower than that of the existing supplier.

Medical consumables enterprises can combine their own advantages to specify which specifications, packaging methods, certification documents and stable delivery arrangements they can provide.

For buyers who are actively looking for new suppliers, the existing cooperating manufacturers may have already met the basic procurement requirements. If a new supplier can only provide the same product name and a quotation, it will be difficult to convince the buyer that it is worth investing additional audit costs.

Enterprises need to make the other party aware of the specific needs their products can meet, and whether they can address certain limitations in the existing procurement channels.

Of course, if the supplier currently cannot meet the buyer's quality standards, registration requirements or delivery conditions, it is also necessary to objectively assess the cooperation possibility, and there is no need to make unfulfillable promises just to be included in the candidate list.

Is it worthwhile to continue maintaining contact when the buyer has no formal procurement plan?

This depends on the likelihood of the enterprise being included in the buyer's supplier list, and whether the future procurement opportunities align with its own business direction.

Some buyers have clearly stated that their current supplier contracts have not yet expired and no procurement will be arranged for the time being, but they hope to audit new manufacturers in advance. Although such projects do not bring orders in the short term, they can still be regarded as long-term development leads if the products match and the audit process is clear.

There are also some buyers who are only collecting supplier information broadly, without specifying clear specifications, quantities, or being willing to further explain the procurement background. For this type of lead, enterprises can maintain regular contact, but should not invest a large amount of technical or commercial resources prematurely.

During the supplier assessment process, whether the buyer is willing to clarify the existing procurement needs, provide clear quality standards, arrange document reviews, and whether there is an estimated procurement time, all can help the enterprise judge the actual progress of the project.

For some pharmaceutical products, being included in the qualified supplier list does not guarantee that orders will be obtained. The purchaser may still allocate the procurement volume among multiple qualified suppliers based on price, production capacity, project needs and actual supply conditions.

Therefore, enterprises should attach importance to the opportunity of being included in the procurement list, while also taking a rational view of the time gap from supplier audit to actual transaction.

The online product display of enterprises also affects whether new buyers can discover them

When overseas buyers look for new suppliers, in addition to exhibition recommendations and existing business channels, they may also search for eligible enterprises through search engines, industry platforms and product catalogs.

For example, when an overseas pharmaceutical factory is preparing to find a new API supply source, they may directly search using keywords such as the product's English name, CAS number, quality standards or manufacturer-related information. Medical device distributors may screen suppliers based on specific equipment models, product uses, certifications and OEM requirements.

If an enterprise only has a brief company introduction online, lacking information on core products, specifications, quality standards and supply capacity, it may be difficult to enter the preliminary screening range of buyers even if it has the corresponding production conditions.

On professional pharmaceutical B2B platforms such as Drugdu.com, enterprises can display their main products, supply capacity and relevant qualifications through product pages and corporate homepages, creating an entry for overseas buyers to learn about suppliers.

For enterprises that are preparing to expand overseas customers, especially mature manufacturers with proven products and export experience, it is worthwhile to prioritize improving the English names, specifications, quality standards, packaging and available document information of several key products, while keeping the company introduction and contact information accurate.

This information cannot replace the buyer's supplier audit, nor can it guarantee that the enterprise will receive procurement orders, but it can help potential purchasers judge whether the enterprise meets their needs during the initial search.

Overseas buyers who already have fixed suppliers but are still looking for new Chinese manufacturers may aim to control supply risks, increase procurement options, or reserve resources in advance for future new projects.

For suppliers, this type of customer may not bring orders in the short term, but they should not directly dismiss the development value just because the other party already has a cooperating manufacturer.

It is worth noting whether the buyer has clear product requirements, formal procurement and audit capabilities, and whether the enterprise itself has the conditions to be included in the other party's supply system.

In pharmaceutical foreign trade, some cooperation opportunities do not result in orders at the first inquiry. By maintaining accurate and complete product displays, enterprises can make it possible for overseas buyers to find them when they are looking for alternative suppliers, which also increases the chances for future cooperation.

"/

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.